Drug Screening Market Report
The report on the Global Drug Screening Market is segmented by Product & Services (Analytical Instruments, Rapid Testing Devices, Consumables, Drug Screening Services), By Sample Type (Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Other), By End User (Workplace, Criminal Justice Systems and Law Enforcement Agencies, Drug Treatment Centers, Pain Management Centers, Drug Testing Laboratories, Others), and Region. It also covers the COVID-19 Impact Analysis and Forecast to 2026. This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global Drug Screening market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
The report on the Global Drug Screening Market is segmented by Product & Services (Analytical Instruments, Rapid Testing Devices, Consumables, Drug Screening Services), By Sample Type (Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Other), By End User ...
The Global Drug Screening Market is estimated to grow from USD 4.4 billion in 2020 to USD 11.1 billion by 2026 at a healthy CAGR of 17% during the forecast period.
Figure: Global Drug Screening Market Size, 2020-2026 (USD Billion)
Wish to get a free sample? Click here.
Drug screening is defined as the process of collecting and analysing blood, hair, urine, or saliva to detect the presence of contaminants and chemicals left in the body as a result of drug consumption. In this process, potential drugs are identified and optimized before selecting a candidate drug for a clinical trial. Drug screening is done in order to determine if a person is or has consumed drugs at a certain point of time.
Key players operating in the global Drug screening market are-
Increasing drug and alcohol testing measures in various countries to curb the menace of drug and alcohol abuse is likely to drive the market growth significantly.
The workplace segment accounted for the largest market share in 2020.
Based on end user, the market has been divided into workplace, criminal justice systems and law enforcement agencies, drug treatment centers, pain management centers, drug testing laboratories and others. The segment growth can be attributed to rising safety concern for the staff.
The market in North America accounted for the largest share in 2020 due to the high consumption of drugs and alcohol. Additionally, supporting government measures to curb the use of drugs is likely to add significantly to the market growth. The market in Europe accounted for the second-largest market share in 2020.
The covid-19 outbreak affected the growth of the drug screening market for a short period of time due to disruption in business and economic activities across geographies. Postponement of non-essential medical services amid the covid-19 outbreak also affected the growth of the drug screening market. However, with the reopening of the economy, the market is likely to experience growth during the review period.
Get a free sample Here...
Here is the list of the group of customers that the Global Drug Screening Market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
The drug screening market size is expected to reach USD 11.1 billion in the foreseeable future.
Alere Inc. (The U.S), Laboratory Corporation of America Holdings (The U.S), OraSure Technologies (The U.S), Quest Diagnostics (The U.S), Thermo Fisher Scientific (The U.S), Alfa Scientific Designs, Inc. (The U.S), MPD Inc. (The U.S), Lifeloc Technologies, Inc. (The U.S), Omega Laboratories Inc. (The U.S), Sciteck Diagnostics Inc (The U.S), ACM GLOBAL LABORATORIES (The U.S), and Carehealth America Corporation (The U.S) are among the key players in the drug screening market.
The drug screening market is expected to grow at an impressive CAGR of 17% in the coming years.
North America accounted for the largest share of the drug screening market in 2020.
The workplace segment accounted for the largest share of the drug screening market in 2020.
Increasing drug and alcohol testing measures in various countries to curb the menace of drug and alcohol abuse, increase in consumption of drugs and alcohol across the geographies particularly among the youth and elder population are the factors driving the growth of drug screening market.
Drug screening distributors, Drug screening suppliers, Drug screening manufacturers, Logistics organizations, Government Bodies are the target audience in the drug screening market.